Navigation Links
Flu focus: NIH project aims for better drugs
Date:10/20/2009

HOUSTON -- (Oct. 20, 2009) -- Rice University scientists have won a $1.5 million grant from the National Institutes of Health to scrutinize the influenza A virus for clues that could lead to more effective antiviral drugs. Strains of influenza A include this year's pandemic H1N1 variety, some seasonal varieties and the much-feared H5N1 bird flu.

Under the four-year program, biochemists in the laboratory of Rice's Jane Tao will continue their groundbreaking investigations into the form and function of nucleoprotein (NP), one of fewer than a dozen proteins encoded by the flu virus.

All varieties of influenza A consist of variants of just eight genes --encoded in RNA -- that produce 11 proteins. But for all its apparent simplicity, the disease behaves in complex ways that have stymied scientists for decades.

For instance, when flu particles dock with healthy cells, they inject their genetic payload into the cell and hijack the cell's own machinery to make copies of themselves. Based on previous research -- including an influential 2006 report by Tao and University of Texas at Austin colleague Robert Krug -- scientists know the flu can replicate only when all eight genes are packaged in a particular way. Tao, who first deciphered the atomic structure of NP for that study, said the new research program will go a step further by systematically investigating NP's role in building the RNA package that's so critical for the virus to reproduce.

"This particular form is very important for the RNA to function as a template, but we do not understand how the flu packages only the eight segments that it needs and in the right order," Tao said. "It's the specificity that's intriguing. If you package eight random segments of RNA, the chances of getting a viable virus are very low."

Scientists know that in the viable package, NPs are stacked atop one another -- much of like vertebrae in a spine -- and the RNA segments wrap around the stack. A protein complex called the polymerase, which is attached at the end of RNA, helps kick off replication once the assembly is injected into a healthy cell.

Tao said her team will use several techniques, including X-ray crystallography and electron cryomicroscopy, to obtain the first three-dimensional structure of the RNA-wrapped NP complex, a structure known as the ribonucleoprotein complex. The group will also purify individual segments of RNA, NP and polymerase; using some painstaking trial-and-error tests, they also will try to decipher the order and arrangements that must be brought together to create a viable ribonucleoprotein.

Krug's group will help determine the function of the various NP structures in replicating the viral RNA segments in cells, as well as how amino acid changes in the NP structure affect the ability of NP to function with the polymerase.

"We want to understand the assembly process," Tao said. "How do all those molecules come together? Obviously it cannot happen all at once. It must take place in a sequential manner, but that process is very poorly understood at the moment."

Krug said the funding for the project -- which comes from the American Recovery and Reinvestment Act -- arrives at a fortuitous time. "The flu is front and center in people's minds right now because of H1N1, and thanks to this grant, we're able to pursue an important new line of research that could answer fundamental questions about the disease."


'/>"/>

Contact: Jade Boyd
jadeboyd@rice.edu
713-348-6778
Rice University
Source:Eurekalert

Related biology news :

1. LaserCard Corporation Announces Expansion of Middle East Project
2. UD leads $5.3-million research project on rice epigenetics
3. RSC Project Prospect scoops prestigious award
4. UD leads $5.3-million research project on rice epigenetics
5. USC biomedical team to participate in $6 million low vision project
6. Green alga genome project catalogs carbon capture machinery
7. USDA Cooperative Agreement funds mosquito project at Rutgers
8. Life-saving clean water project secures $13M from Bill & Melinda Gates Foundation
9. UW launches cutting-edge DNA fin-printing project for salmon
10. BIO-key(R) PocketCop(R) Project Leading the Nation According to Televised Report
11. Are current projections of climate change-impacts on biodiversity misleading?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2017)... the thousands of attendees at this year,s International Consumer Electronics Show (CES), ... measurement devices and services, will be featuring its new line of ULTRA ... special CES Exhibit Suite , the new upper arm and wrist ... WellnessConnected product platform.  Continue Reading ... ...
(Date:12/20/2016)... 2016 The rising popularity of mobility ... is stoking significant interest in keyless access systems. ... low energy (BLE), biometrics and near-field communication (NFC) ... of wireless technologies in the automotive industry. This ... access systems opens the market to specialist companies ...
(Date:12/16/2016)... 16, 2016 The global wearable medical device market, in ... 2021 from USD 5.31 billion in 2016, at a CAGR of ... ... technological advancements in medical devices, launch of a growing number of ... connectivity among healthcare providers, and increasing focus on physical fitness. ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... 19, 2017 Research and Markets has announced ... Biomolecules, Cancer Type, Application - Global Opportunity Analysis and Industry Forecast, ... ... global market is projected to reach $15,737 million by 2022 from ... to 2022. Omic technologies segment accounted for more ...
(Date:1/19/2017)... (PRWEB) , ... January 19, ... ... of advanced software solutions for pharmaceutical research and development (R&D), today announced ... in omic data analysis and interpretation for the rapidly evolving field of ...
(Date:1/19/2017)... (PRWEB) , ... January 18, 2017 , ... ... National Institutes of Health (NIH) to update its Data Sharing Policy. Specifically, the ... element of grant applications subject to the existing policy. AMIA recommended that NIH ...
(Date:1/19/2017)... Md. , Jan. 18, 2017  Northwest Biotherapeutics, ... developing DCVax® personalized immune therapies for operable and inoperable ... Bosch , Chief Technical Officer of NW Bio, will ... January 19, 2017, at the Hyatt Regency Hotel in ... Bosch will chair the session entitled "New Therapeutic Approaches ...
Breaking Biology Technology: